Arcadia Biosciences (NASDAQ: RKDA) before the bell said its joint venture with Bioceres S.A., Verdeca, has received notification that the FDA has completed its full review of the company’s safety evaluation for HB4 soybeans. This permits Verdeca products derived from HB4 soybeans to be used commercially in human food and animal feed. Additionally, completion of the FDA’s review marks a key regulatory achievement in the approval process for Verdeca’s HB4 drought stress tolerance trait. The company has submitted an environmental safety data petition to the U.S. Department of Agriculture (USDA) which is currently under review. The USDA is expected to issue a Determination on Nonregulated Status upon completion of review, which will complete the approval processes in the U.S. and allow for commercial production of HB4 soybeans. “Our combined efforts aim to create significant value for soybean growers by increasing the productivity and sustainability of this important protein crop in the face of global climate challenges,” Arcadia Biosciences president and CEO Raj Ketkar stated in the news release.
To view the full press release, visit: http://nnw.fm/D4lQw
About Arcadia Biosciences, Inc.
Based in Davis, Calif., Arcadia Biosciences (Nasdaq: RKDA) develops agricultural products that create added value for farmers while benefitting the environment and enhancing human health. Arcadia’s agronomic performance traits, including Nitrogen Use Efficiency, Water Use Efficiency, Salinity Tolerance, Heat Tolerance and Herbicide Tolerance, are all aimed at making agricultural production more economically efficient and environmentally sound. Arcadia’s nutrition traits and products are aimed at creating healthier ingredients and whole foods with lower production costs. For more information, visit www.ArcadiaBio.com.
More from CannabisNewsBreaks
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.CannabisNewsWire.com